Try our beta test site
3 studies found for:    16585157 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
Conditions: Breast Cancer;   Colon Cancer;   Pancreatic Cancer;   Sarcoma;   Ovarian Cancer
Interventions: Biological: p53: 264-272 peptide;   Drug: CT-011
2 Recruiting Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab
3 Recruiting Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pembrolizumab;   Drug: Carboplatin;   Drug: Paclitaxel

Study has passed its completion date and status has not been verified in more than two years.